PlainRecalls
FDA Drug Low Class III Terminated

Fentanyl Transdermal System, 100 mcg/h, packaged in 5 pouch system (NDC 0591-3214-72), Rx Only, Manufactured by: Actavis Laboratoies UT, Inc. Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054 USA. Individual pouch NDC 0591-3214-54.

Reported: February 14, 2018 Initiated: January 29, 2018 #D-0543-2018

Product Description

Fentanyl Transdermal System, 100 mcg/h, packaged in 5 pouch system (NDC 0591-3214-72), Rx Only, Manufactured by: Actavis Laboratoies UT, Inc. Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054 USA. Individual pouch NDC 0591-3214-54.

Reason for Recall

Failed Impurities/Degradation Specifications: Fentanyl-n-Oxide (FNO) degradant exceeding the specification limits

Details

Recalling Firm
Teva Pharmaceuticals USA
Units Affected
554, 562 (5 pouches/carton)
Distribution
Distributed nationwide within the United States
Location
North Wales, PA

Frequently Asked Questions

What product was recalled?
Fentanyl Transdermal System, 100 mcg/h, packaged in 5 pouch system (NDC 0591-3214-72), Rx Only, Manufactured by: Actavis Laboratoies UT, Inc. Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054 USA. Individual pouch NDC 0591-3214-54.. Recalled by Teva Pharmaceuticals USA. Units affected: 554, 562 (5 pouches/carton).
Why was this product recalled?
Failed Impurities/Degradation Specifications: Fentanyl-n-Oxide (FNO) degradant exceeding the specification limits
Which agency issued this recall?
This recall was issued by the FDA Drug on February 14, 2018. Severity: Low. Recall number: D-0543-2018.